Ekso Bionics
EKSO
Ekso Bionics (EKSO) - P/B ratio
P/B ratio as of June 2024 : 1.36
According to Ekso Bionics
's latest financial reports the company has a price-to-book ratio of 1.36.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Ekso Bionics - P/B ratio (from 2014 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 2.82 | 359.24% |
| 2022-12-31 | 0.6147 | -31.82% |
| 2021-12-31 | 0.9017 | -92.16% |
| 2020-12-31 | 11.5 | 129.94% |
| 2019-12-31 | 5.00 | -82.53% |
| 2018-12-31 | 28.6 | 379.8% |
| 2017-12-31 | 5.96 | -55.27% |
| 2016-12-31 | 13.3 | 9.46% |
| 2015-12-31 | 12.2 | 100.96% |
| 2014-12-31 | 6.06 | |
| 2013-12-31 | N/A | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 STAAR Surgical STAA | 5.85 | 330.75% | 🇺🇸 USA |
 OraSure Technologies OSUR | 0.7322 | -46.09% | 🇺🇸 USA |
 AtriCure ATRC | 2.47 | 81.82% | 🇺🇸 USA |
 Biolase
BIOL | 8.96 | 559.97% | 🇺🇸 USA |